Partial replicate design & ABE for the FDA [Design Issues]

posted by nobody – 2017-03-06 15:18 (3401 d 16:28 ago) – Posting: # 17141
Views: 13,890

Les Benet at the BioInternational ’94 in Munich. You’ve been there…


Nice location, btw. ;-) (you still have the list of participants? ***glotz***)

...but even some 10 years ago (and later) from time to time this sentiment came up from Schlipsträgers...

Re. Test better than Ref: But you can't know in advance and if you have a look at some of the "companies" nowadays "developing" generics your "gut feeling"/experience from the past might be subjected to some change (as so many things nowadays...)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
375 visitors (0 registered, 375 guests [including 21 identified bots]).
Forum time: 08:46 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5